BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18929760)

  • 1. The potential value of natural antioxidative treatment in glaucoma.
    Mozaffarieh M; Grieshaber MC; Orgül S; Flammer J
    Surv Ophthalmol; 2008; 53(5):479-505. PubMed ID: 18929760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there more to glaucoma treatment than lowering IOP?
    Mozaffarieh M; Flammer J
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S174-9. PubMed ID: 17998043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of non-IOP lowering therapy for glaucoma].
    Cybulska-Heinrich A; Mozaffarieh M; Flammer J
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):114-9. PubMed ID: 23430676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the present pathogenetic concept of glaucomatous optic neuropathy?
    Flammer J; Mozaffarieh M
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S162-73. PubMed ID: 17998042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
    Attarzadeh A; Hosseini H; Nowroozizadeh S
    Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes in glaucomatous optic neuropathy.
    Hernandez MR; Miao H; Lukas T
    Prog Brain Res; 2008; 173():353-73. PubMed ID: 18929121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative and nitrative stress markers in glaucoma.
    Aslan M; Cort A; Yucel I
    Free Radic Biol Med; 2008 Aug; 45(4):367-76. PubMed ID: 18489911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
    Osborne NN
    Prog Brain Res; 2008; 173():339-52. PubMed ID: 18929120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and glaucoma: injury in the anterior segment of the eye.
    Saccà SC; Izzotti A
    Prog Brain Res; 2008; 173():385-407. PubMed ID: 18929123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel perspective on natural therapeutic approaches in glaucoma therapy.
    Mozaffarieh M; Flammer J
    Expert Opin Emerg Drugs; 2007 May; 12(2):195-8. PubMed ID: 17604496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oxidative stress in glaucoma.
    Izzotti A; Bagnis A; Saccà SC
    Mutat Res; 2006 Mar; 612(2):105-14. PubMed ID: 16413223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and mitochondrial dysfunction in glaucoma.
    Chrysostomou V; Rezania F; Trounce IA; Crowston JG
    Curr Opin Pharmacol; 2013 Feb; 13(1):12-5. PubMed ID: 23069478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted preventive measures and advanced approaches in personalised treatment of glaucoma neuropathy.
    Mozaffarieh M; Fraenkl S; Konieczka K; Flammer J
    EPMA J; 2010 Jun; 1(2):229-35. PubMed ID: 23199061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the link between vascular dysregulation and glaucoma?
    Grieshaber MC; Mozaffarieh M; Flammer J
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S144-54. PubMed ID: 17998040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin in the eye: implications for glaucoma.
    Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP; Rosenstein RE
    Exp Eye Res; 2007 Jun; 84(6):1021-30. PubMed ID: 17174303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights in the pathogenesis and treatment of normal tension glaucoma.
    Mozaffarieh M; Flammer J
    Curr Opin Pharmacol; 2013 Feb; 13(1):43-9. PubMed ID: 23092679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroprotection with carotenoids in glaucoma].
    Neacşu A; Oprean C; Curea M; Tuchilă G; Trifu M
    Oftalmologia; 2003; 59(4):70-5. PubMed ID: 15083692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glaucoma as primary optic neuropathy].
    Nicolae A; Stefan C
    Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.